CLINICAL_TRIALS
trial_result
· 2012-05-28
Clinical Trial Update: Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis [Phase 2]
Summary
A Phase 2 study evaluating peginesatide for maintenance treatment of anemia in participants on hemodialysis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Affymax | Conditions: Anemia, Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-05-28